Boston Scientific invests $1.5 billion in MiRus for TAVR expansion
Deal includes exclusive option to acquire MiRus’ SIEGEL TAVR system for an additional $3 billion upon milestone achievements
Deal includes exclusive option to acquire MiRus’ SIEGEL TAVR system for an additional $3 billion upon milestone achievements
The therapy is suited for patients with severe valve leakage who face elevated surgical risk due to advanced age, frailty, or multiple medical complications
The development comes as stroke remains one of the world’s biggest health threats
Baxfendy works in a fundamentally different way from current therapies
Union Minister Prataprao Jadhav terms hypertension a “silent killer”; experts push for early screening, lifestyle correction and wellness-focused healthcare
The initiative by Rheumatology Association of Gujarat is aimed at strengthening patient-centric autoimmune care
The target reach is of more than 30 million young people and caregivers across 21 countries
Net income more than doubled to 2.763 billion euros, while core earnings per share climbed 12.9 percent to 2.71 euros
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
Subscribe To Our Newsletter & Stay Updated